2-[(4s)-6-(4-chloro-phenyl) -1-methyl-8-(methoxy) -4h-[1,2,4]-triazole-[4,3-a][1,4]-benzo-diazo-4-il]-N-ethyl-acetamide or a salt; drug synthesis and combination; and for the treatment of autoimmune diseases and/or chronic inflammation and cancer.
The present invention relates to a benzodiazepine compound of formula (I), processes for its preparation, pharmaceutical compositions containing such a compound and to its use in therapy.<;p>;2<;/p>;